Tharimmune, Inc.
THAR
$4.72
-$0.25-5.03%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.60M | 6.67M | 6.04M | 5.82M | 5.59M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.11M | 12.63M | 12.43M | 11.12M | 9.10M |
| Operating Income | -12.11M | -12.63M | -12.43M | -11.12M | -9.10M |
| Income Before Tax | -12.01M | -12.48M | -12.20M | -10.85M | -8.88M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.01 | -12.48 | -12.20 | -10.85 | -8.88 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.01M | -12.48M | -12.20M | -10.85M | -8.88M |
| EBIT | -12.11M | -12.63M | -12.43M | -11.12M | -9.10M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -6.23 | -8.00 | -9.56 | -18.11 | -55.08 |
| Normalized Basic EPS | -3.89 | -5.00 | -5.97 | -11.32 | -34.43 |
| EPS Diluted | -6.23 | -8.00 | -9.56 | -18.11 | -55.08 |
| Normalized Diluted EPS | -3.89 | -5.00 | -5.97 | -11.32 | -34.43 |
| Average Basic Shares Outstanding | 8.78M | 6.87M | 5.18M | 3.63M | 2.13M |
| Average Diluted Shares Outstanding | 8.78M | 6.87M | 5.18M | 3.63M | 2.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |